In the fourth quarter of 2008, sales of Botox fell by 3% compared with the same period in 2007.

According to The New York Times, Botox is less hard-hit than many other parts of the cosmetic surgery market because of its relative affordability. Allergan's sales of skin-plumping injections fell 8.8% and breast implants sagged 12%.

It's important to keep in mind that in spite of all the talk about how bad the economy is and how no one has any money, Americans still spent $329 million on Botox last year: the product's second-best outing ever.

The decline of plastic surgery is almost certainly temporary and seems poised to rebound as soon as the economy does. In fact, the short-term return to wrinkles and sagging could lead to pent-up demand and lines at the plastic surgeon when the economy rebounds.

Increase your money and finance knowledge from home

Introduction to Economic Indicators

Measure the performance of the economy.

View Course »

Banking Services 101

Understand your bank's services, and how to get the most from them

View Course »

Add a Comment

*0 / 3000 Character Maximum